2.85
2.06%
-0.06
Handel nachbörslich:
2.87
0.02
+0.70%
Nautilus Biotechnology Inc Aktie (NAUT) Neueste Nachrichten
Clearline Capital LP Lowers Stake in Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World
Insider Selling: Nautilus Biotechnology, Inc. (NASDAQ:NAUT) VP Sells 47,031 Shares of Stock - Defense World
Nautilus Biotechnology senior VP sells over $134k in company stock - Investing.com
Nautilus Biotechnology senior VP sells over $134k in company stock - Investing.com Canada
Nautilus Biotechnology senior VP sells over $134k in company stock - Investing.com India
Nautilus Biotechnology senior VP sells over $134k in company stock - Investing.com UK
Nautilus Biotechnology senior VP sells shares worth over $99k - Investing.com India
Nautilus Biotechnology senior VP sells shares worth over $99k By Investing.com - Investing.com Canada
Nautilus Biotechnology senior VP sells shares worth over $99k By Investing.com - Investing.com Australia
Nautilus Biotechnology senior VP sells shares worth over $99k - Investing.com
Nautilus Biotechnology senior VP sells shares worth over $99k By Investing.com - Investing.com UK
Nautilus Biotechnology Appoints Mass Spectrometry Leader Ken Suzuki as Chief Marketing Officer | Daily - Daily Guardian Canada
Nautilus Biotechnology Appoints Mass Spectrometry Leader Ken Suzuki as Chief Marketing Officer - GlobeNewswire
Nautilus Biotechnology Appoints Mass Spectrometry Leader Ken Suzuki as Chief Marketing Officer - StockTitan
Nautilus Biotechnology Appoints Mass Spectrometry Leader Ken Suzuki as Chief Marketing Officer - Yahoo Finance
Nautilus Biotechnology, Inc.'s (NASDAQ:NAUT) Top Key Executive Parag Mallick is the most upbeat insider, and their holdings increased by 11% last week - Simply Wall St
Nautilus Biotechnology (NASDAQ:NAUT) Stock Price Down 0.8% - MarketBeat
Nautilus Biotechnology Insider Ups Holding During Year - Yahoo Finance
XPeng Inc. (NYSE:XPEV) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World
Vanguard Group Inc. Acquires 29,604 Shares of Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World
Nautilus Biotechnology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference - StockTitan
Nautilus Biotechnology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference - Yahoo Finance
Nautilus Biotechnology (NASDAQ:NAUT) Posts Quarterly Earnings Results, Beats Expectations By $0.02 EPS - MarketBeat
Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q2 2024 Earnings Call Transcript - Insider Monkey
Nautilus Biotechnology, Inc. (NAUT) Q2 2024 Earnings Call Transcript - Seeking Alpha
NAUT Stock Earnings: Nautilus Biotechnology Beats EPS for Q2 2024 - InvestorPlace
Nautilus Down on Releasing Q2 Numbers - Baystreet.ca
Nautilus Biotechnology Reports Second Quarter 2024 Financial Results - GlobeNewswire
Nautilus Biotechnology Reports Second Quarter 2024 Financial Results - StockTitan
Nautilus Biotechnology Reports Second Quarter 2024 Financial Results - Yahoo Finance
We're Not Very Worried About Nautilus Biotechnology's (NASDAQ:NAUT) Cash Burn Rate - Simply Wall St
Hybrid Software Group PLC Publishes 2024 Interim Report - Yahoo Finance UK
Nautilus Biotechnology (NAUT) Set to Announce Earnings on Tuesday - Defense World
Nautilus Biotechnology (NAUT) to Release Earnings on Tuesday - MarketBeat
Nautilus Biotechnology (NASDAQ:NAUT) Stock Price Down 2.5% - MarketBeat
Short Interest in Graco Inc. (NYSE:GGG) Rises By 6.2% - Defense World
Zacks Research Research Analysts Lower Earnings Estimates for Embraer S.A. (NYSE:ERJ) - Defense World
Nautilus Biotechnology (NASDAQ:NAUT) Trading Down 2.5% - Defense World
Analysts Issue Forecasts for IDEAYA Biosciences, Inc.’s Q2 2024 Earnings (NASDAQ:IDYA) - Defense World
AI-Enabled Biotech - Madrona Venture Group
Revolutionizing Proteomics: Sujal Patel, Co-Founder & CEO of Nautilus, on Drug Development - Audacy
Nautilus Biotechnology to Announce Second Quarter 2024 Financial Results on July 30, 2024 - GlobeNewswire
Nautilus Biotechnology to Announce Second Quarter 2024 Financial Results on July 30, 2024 - Yahoo Finance
With 32% ownership, Nautilus Biotechnology, Inc. (NASDAQ:NAUT) insiders have a lot riding on the company's future - Yahoo Finance
Owning 33% in Nautilus Biotechnology, Inc. (NASDAQ:NAUT) means that insiders are heavily invested in the ... - Yahoo New Zealand News
Nautilus Biotechnology (NASDAQ:NAUT) Coverage Initiated by Analysts at Guggenheim - Defense World
Analyst sets Nautilus Biotech shares at Buy on innovative technology By Investing.com - Investing.com Australia
Analyst sets Nautilus Biotech shares at Buy on innovative technology By Investing.com - Investing.com India
Amerant Bank appoints new Palm Beach Market President By Investing.com - Investing.com
Guggenheim Initiates Coverage on Nautilus Biotechnology (NASDAQ:NAUT) - MarketBeat
Guggenheim Initiates Coverage of Nautilus Biotechnology (NAUT) with Buy Recommendation - Nasdaq
Insiders Give Up US$20k As Nautilus Biotechnology Stock Drops To US$2.41 - Simply Wall St
Keeping an Eye on Nautilus Biotechnology Inc (NAUT) After Insider Trading Activity – Knox Daily - Knox Daily
Perceptive Advisors LLC Acquires 3,483,060 Shares of Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - MarketBeat
Nautilus Biotechnology directors elected, auditor ratified By Investing.com - Investing.com
Despite Nautilus Biotechnology's Pullback, Insiders Still Gained US$167k - Yahoo Lifestyle Australia
Proteomics platform sheds new light on tau’s role in Alzheimer’s - Longevity.Technology
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday - The Globe and Mail
Tencent (OTCMKTS:TCEHY) Stock Passes Above Two Hundred Day Moving Average of $39.85 - Defense World
Pacific Biosciences of California (NASDAQ:PACB) Receives New Coverage from Analysts at Jefferies Financial Group - Defense World
Proficient Auto Logistics (NASDAQ:PAL) Now Covered by Analysts at Raymond James - Defense World
Proficient Auto Logistics (NASDAQ:PAL) Now Covered by Analysts at William Blair - Defense World
Puma Biotechnology (NASDAQ:PBYI) Given “Buy” Rating at HC Wainwright - Defense World
Nautilus Biotechnology (NASDAQ:NAUT) Earns Hold Rating from Analysts at Jefferies Financial Group - MarketBeat
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):